NCT04967378

Brief Summary

This study aims to develop, implement, and assess the feasibility, acceptability, and preliminary efficacy of a 10-week structured and individualized cognitive-emotional intervention program for homebound older adults with Mild Cognitive Impairment (MCI) and with depressive and/or anxiety symptoms. Homebound Elderly People Psychotherapeutic Intervention (HEPPI) is designed to maintain or improve memory functioning, reduce depressive and/or anxiety symptoms, and help participants to compensate or adapt to impaired cognitive performance, improving their quality of life and their subjective perception of memory and health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 19, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

June 8, 2022

Status Verified

June 1, 2022

Enrollment Period

1.2 years

First QC Date

June 19, 2021

Last Update Submit

June 3, 2022

Conditions

Keywords

Homebound Older AdultsMild Cognitive ImpairmentDepressive and Anxious SymptomatologyCognitive-Emotional Intervention Program

Outcome Measures

Primary Outcomes (3)

  • Feasibility of HEPPI program

    Measured by recruitment rate

    Baseline

  • Feasibility of HEPPI program

    Measured by drop-out rate

    Immediately after the intervention

  • Acceptability of HEPPI program

    Assessed with a questionnaire that includes questions regarding the participants' satisfaction with the program, their intention to use the program, the usefulness and relevance of the program, and its demandingness.

    1 week after the intervention

Secondary Outcomes (9)

  • Changes in General Cognitive Function

    Baseline, 1 week after the intervention

  • Changes in Verbal Memory

    Baseline, 1 week after the intervention

  • Changes in Episodic Memory

    Baseline, 1 week after the intervention

  • Changes in Sustained Attention

    Baseline, 1 week after the intervention

  • Changes in Depressive Symptomatology

    Baseline, 1 week after the intervention

  • +4 more secondary outcomes

Study Arms (2)

HEPPI program

EXPERIMENTAL
Behavioral: HEPPI

Waiting-list control group

NO INTERVENTION

Receives access to HEPPI program at the end of the study.

Interventions

HEPPIBEHAVIORAL

10 weekly individual sessions, 90 minutes each, at the participants' homes. The content of sessions includes psychoeducation, cognitive training, psychotherapeutic intervention, and compensatory strategy training.

Also known as: Homebound Elderly People Psychotherapeutic Intervention
HEPPI program

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Homebound older adults over 65 years old;
  • Presence of aMCI;
  • Presence of depressive and/or anxiety symptoms;
  • Residence in mainland Portugal;
  • Provision of written informed consent by participants.

You may not qualify if:

  • Presence of a dementia diagnosis;
  • Presence or history of other significant neurological conditions;
  • Presence of severe psychiatric illnesses;
  • Presence of comorbid medical conditions associated with cognition decline;
  • Use of psychotropic medication;
  • Presence of alcoholism or toxicomania;
  • Significant impairment of vision, hearing, communication or manual dexterity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Research in Neuropsychology and Cognitive Behavioral Intervention (CINEICC)

Coimbra, 3000, Portugal

Location

MeSH Terms

Conditions

Cognitive DysfunctionDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Integrated non-PhD member

Study Record Dates

First Submitted

June 19, 2021

First Posted

July 19, 2021

Study Start

June 1, 2020

Primary Completion

August 31, 2021

Study Completion

December 31, 2021

Last Updated

June 8, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations